This Week at FDA: QMSR and PreCheck Kickoff, Makary Tries to Ease CNPV Concerns, and MoreFebruary 6, 2026February 9, 2026
This Week at FDA: HHS Ends Aborted Fetal Tissue Research, PreCheck Pilot Update, and MoreJanuary 23, 2026February 5, 2026
This Week at FDA: Drug Voucher Program Hits a Snag, GOP Targets Abortion Drug, and MoreJanuary 16, 2026January 17, 2026
FDA and EMA Release Guiding Principles of Good AI Practice in Drug DevelopmentJanuary 14, 2026January 14, 2026
This Week at FDA: FDA Eases Digital Health Oversight, MDUFA Negotiation Update, and MoreJanuary 9, 2026January 14, 2026
This Week at FDA: FDA Staff Raise Alarm Over CNVP, No COVID-19 Vaccine Boxed Warning, and MoreDecember 19, 2025December 23, 2025
This Week at FDA: Anti-abortion Groups Want Makary Fired, FDA Investigating RSV VaccinesDecember 12, 2025December 13, 2025
FDA Qualifies First AI Drug Development Tool, Will Be Used in ‘MASH’ Clinical TrialsDecember 9, 2025December 13, 2025
